These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7550678)

  • 1. In vivo and in vitro production of monoclonal antibodies. Bioreactors vs immune ascites.
    Marx U; Merz W
    Methods Mol Biol; 1995; 45():169-76. PubMed ID: 7550678
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Discussion.
    Hendriksen CF; de Leeuw WA
    Res Immunol; 1998; 149(6):611-20. PubMed ID: 9835427
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamic reoptimization of a fed-batch fermentor.
    Iyer MS; Wiesner TF; Rhinehart RR
    Biotechnol Bioeng; 1999 Apr; 63(1):10-21. PubMed ID: 10099577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for the production of xenogeneic monoclonal antibodies in murine ascites.
    Weissman D; Parker DJ; Rothstein TL; Marshak-Rothstein A
    J Immunol; 1985 Aug; 135(2):1001-3. PubMed ID: 4008923
    [No Abstract]   [Full Text] [Related]  

  • 6. Hollow fibre bioreactors: an alternative to murine ascites for small scale (<1 gram) monoclonal antibody production.
    Lipman NS; Jackson LR
    Res Immunol; 1998; 149(6):571-6. PubMed ID: 9835420
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Introduction.
    de Geus B; Hendriksen CF
    Res Immunol; 1998; 149(6):533-4. PubMed ID: 9835413
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of rat monoclonal antibodies specific for mouse integrins.
    Delcommenne M; Streuli CH
    Methods Mol Biol; 1999; 129():19-34. PubMed ID: 10494555
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies.
    Marx U
    Res Immunol; 1998; 149(6):557-9. PubMed ID: 9835418
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive control of hollow-fiber bioreactors for the production of monoclonal antibodies.
    Dowd JE; Weber I; Rodriguez B; Piret JM; Kwok KE
    Biotechnol Bioeng; 1999 May; 63(4):484-92. PubMed ID: 10099629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations for in vitro monoclonal antibody production.
    Peterson NC
    Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody production: problems and solutions.
    Falkenberg FW
    Res Immunol; 1998; 149(6):542-7. PubMed ID: 9835415
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
    Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
    J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody production in murine ascites. II. Production characteristics.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):81-6. PubMed ID: 10090099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods.
    Falkenberg FW
    Res Immunol; 1998; 149(6):560-70. PubMed ID: 9835419
    [No Abstract]   [Full Text] [Related]  

  • 16. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody production in murine ascites. I. Clinical and pathologic features.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    Lab Anim Sci; 1999 Feb; 49(1):70-80. PubMed ID: 10090098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of monoclonal antibody supernatant and ascites fluid.
    Yokoyama WM
    Curr Protoc Mol Biol; 2008 Jul; Chapter 11():Unit 11.10. PubMed ID: 18633992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.